CAPABILITIES & EQUIPMENT
• 75-Bed, state-of-the-art Phase I Unit
• Over 1,000 Phase I-IV clinical trials successfully conducted
• Over 150 Phase I trials executed
• First in Human
• Single and Multiple Ascending Dose
• PK/PD
• QTc and Cardiac Safety
• Bioequivalence/Bioavailability
• Food Effect
• Biologics, including Monoclonal Antibody
• Proof-of-Concept
• Protocol Design and Development
• Statistical Analysis and Report Writing
• Intellectual Property Development and Regulatory Filing
• Drug Interaction
Mortara 12-Lead Wireless Telemetry
• Polysomnography
• DEXA Scanner
• Neuropsychological and Cognitive Testing
• Echocardiogram
• Plethysmography
• MRA and CT scanning
• Digital X-ray
• Endoscopy
• Ultrasound
• Full-service Clinical Laboratory, CLIA and COLA Certified
• ECGs
• Pulmonary Function Testing
• Holter monitoring
• Freezers (-20/-70/-80)
• Long-term Liquid Nitrogen sample storage
• Peripheral Blood Mononuclear Cell (PBMC) Isolation
• 30,000+ Subject Database
• Central IRB, 5-day turn around on contracts and regulatory
• Clinical RSVP – statewide fingerprinting system ensuring subjects not enrolled into another study
AAHRPP Certified – One of only two non-academic research centers to receive this prestigious
   subject safety recognition
• Adjacent to South Miami Hospital’s top-notch Emergency Room
SPECIAL POPULATIONS
• Elderly
• Diabetes
• Renal
• Hepatic
• CNS
• Psychiatry
• Pediatric
• SLE
• Rheumatoid Arthritis
• Asthma/COPD
• Obesity
• Hypertension
• Birth control
• Allergies
• Psoriasis
• Women’s Health
 

Center Overview | Early Phase Trials | Late Phase Trials | Subject Recruitment | MRA Pharmacy | MRA Laboratory | Data Management
Contact MRA | MRA Home Page | Sponsor's Home Page | Volunteer's Home Page

© 2013-2014 Miami Research Associates, LLC. All rights reserved.